Latest in Immunotherapy for Breast Cancer in 2023

HER2 Positive, Negative or Low? Breast Cancer Updates in 2023Подробнее

SABCS 2023: A Look into New Research for Inflammatory Breast CancerПодробнее

Highlights from SABCS 2023: the future of immunotherapy in higher-risk ER+ breast cancerПодробнее

Breast Cancer Breakthroughs: Clinical Trial Results from SABCS 2023Подробнее

Report Back from 2023 San Antonio Breast Cancer Symposium (SABCS)Подробнее

Top 5 Breast/GYN Cancer Advances in 2023: #3 Immunotherapy UpdatesПодробнее

Immunotherapy #16 | New Lip Products | My Blood Pressure was HIGH #immunotherapy #breastcancerПодробнее

Breast Cancer Breakthroughs Episode 6: Highlights from SABCS 2023Подробнее

UCSF Bay Area Breast Cancer Forum: Updates from ESMO 2023Подробнее

SABCS 2023 Breast Cancer Highlights – NSABP B-51, IDEA Update, ICARO, Keynote 522 UpdateПодробнее

4 breast cancer breakthroughs that will change lives - with Dr TashaПодробнее

What’s New in Breast Cancer? | 2023 Forum for Young Adults with Breast CancerПодробнее

Hopeful Breakthrough In Treatment For Breast Cancer | 10 News FirstПодробнее

Patient Immunotherapy Summit: Breast Cancer BriefПодробнее

CRI’s 7th Annual Patient Immunotherapy Summit - December 2023 Full CutПодробнее

Cancer, Immunity, and Immunotherapy - Part 1 (2023 Update)Подробнее

Breast Cancer Update with Dr. Parvin PeddiПодробнее

Latest Treatment Options for Breast CancerПодробнее

ESMO 2023 Breast Cancer Highlights – Keynote 756, TROPION-Breast01, Keynote 52 | Onc BrothersПодробнее

Research Update for HER2-Positive MBC | 2023-2024 EMBRACE MBC Virtual Forum SeriesПодробнее